Jan Eckmann

669 total citations
5 papers, 34 citations indexed

About

Jan Eckmann is a scholar working on Oncology, Hematology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jan Eckmann has authored 5 papers receiving a total of 34 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Hematology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jan Eckmann's work include Monoclonal and Polyclonal Antibodies Research (2 papers), Immune Cell Function and Interaction (2 papers) and CAR-T cell therapy research (2 papers). Jan Eckmann is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (2 papers), Immune Cell Function and Interaction (2 papers) and CAR-T cell therapy research (2 papers). Jan Eckmann collaborates with scholars based in Switzerland and Germany. Jan Eckmann's co-authors include Carola H. Ries, Gordon F. Heidkamp, Falk Nimmerjahn, Sabine Hoves, Christian Klein, Vaios Karanikas, Pablo Umaña, Marco Berrera, Bruno C. Medeiros and Carina Hage and has published in prestigious journals such as Blood, Cancer Research and Frontiers in Immunology.

In The Last Decade

Jan Eckmann

4 papers receiving 33 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Eckmann Switzerland 3 18 15 11 9 4 5 34
Aliya Holland United States 4 20 1.1× 14 0.9× 9 0.8× 8 0.9× 2 0.5× 5 38
Elif Gokdemir United States 3 41 2.3× 20 1.3× 10 0.9× 15 1.7× 3 0.8× 4 47
Lisa Rohrbacher Germany 3 15 0.8× 13 0.9× 7 0.6× 9 1.0× 1 0.3× 10 28
Catherine Robertson United States 3 11 0.6× 30 2.0× 13 1.2× 4 0.4× 1 0.3× 5 36
Suki Subbiah United States 5 12 0.7× 31 2.1× 10 0.9× 5 0.6× 1 0.3× 12 50
Neus Ruiz‐Xivillé Spain 6 8 0.4× 8 0.5× 10 0.9× 15 1.7× 8 34
Idoia García‐Ramírez Spain 4 7 0.4× 10 0.7× 25 2.3× 13 1.4× 2 0.5× 6 41
A. Digiacomo Italy 3 27 1.5× 14 0.9× 12 1.1× 3 0.3× 8 2.0× 4 47
I. V. Kryuchkova Russia 5 25 1.4× 7 0.5× 8 0.7× 21 2.3× 10 52
Yvette Wood United Kingdom 2 18 1.0× 36 2.4× 14 1.3× 3 0.3× 2 0.5× 2 41

Countries citing papers authored by Jan Eckmann

Since Specialization
Citations

This map shows the geographic impact of Jan Eckmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Eckmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Eckmann more than expected).

Fields of papers citing papers by Jan Eckmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Eckmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Eckmann. The network helps show where Jan Eckmann may publish in the future.

Co-authorship network of co-authors of Jan Eckmann

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Eckmann. A scholar is included among the top collaborators of Jan Eckmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Eckmann. Jan Eckmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Renner, Florian, Jan Eckmann, Nicole A. Kratochwil, et al.. (2025). Abstract 5606: The novel brain-penetrant paradox breaker BRAF inhibitor RG6344 manifests exceptional activity in BRAF mutant colorectal cancers. Cancer Research. 85(8_Supplement_1). 5606–5606.
2.
Korfi, Koorosh, Bruno C. Medeiros, Marco Berrera, et al.. (2023). CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemia. Frontiers in Oncology. 13. 1150149–1150149. 6 indexed citations
3.
Eckmann, Jan, et al.. (2023). Early Intervention with Celmods, but Not Imids, Prevents Relapse to Forimtamig Driven By GPRC5D-Negative Myeloma Cells. Blood. 142(Supplement 1). 4659–4659. 5 indexed citations
4.
5.
Hoves, Sabine, et al.. (2020). The Tumor Milieu Promotes Functional Human Tumor-Resident Plasmacytoid Dendritic Cells in Humanized Mouse Models. Frontiers in Immunology. 11. 2082–2082. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aliya Holland Breakdown of academic impact, for papers by Elif Gokdemir Breakdown of academic impact, for papers by Lisa Rohrbacher Breakdown of academic impact, for papers by Catherine Robertson Breakdown of academic impact, for papers by Suki Subbiah Breakdown of academic impact, for papers by Neus Ruiz‐Xivillé Breakdown of academic impact, for papers by Idoia García‐Ramírez Breakdown of academic impact, for papers by A. Digiacomo Breakdown of academic impact, for papers by I. V. Kryuchkova Breakdown of academic impact, for papers by Yvette Wood
Rankless by CCL
2026